Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
GlaxoSmithKline
1748
GlaxoSmithKline
Health
Health and Wellness
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
We’re a science-led global healthcare company on a mission to help people to do more, feel better, live longer. Twitter code of conduct on our site
Suggest edits
Type
B2c
Founded
1830
Follow us
Also headquartered in London
Blockchain
Reuters
Springwise
BBC
HSBC
DeepMind
Revolut
Volkswagen
Cambridge Analytica
Ubuntu
Companies in the same industry
Bioquark Inc.
Esperion Therapeutics
Bristol-Myers Squibb
Prexton Therapeutics SA
Genomera
Chantest
Pearl Therapeutics
ImmunoBiochem Corporation
Attenua
Rex Animal Health
Alexa global traffic share
Twitter followers
Overview
Investments
8
Apps
55
Add info
Acquired by
03 Dec 2018
Hindustan Unilever
€3,300,000,000
03 Dec 2018
Hindustan Unilever
€3,300,000,000
Location
London
,
United Kingdom
Headquarters
Explore London
VCCircle
GlaxoSmithKline to sell Karnataka plant to Hetero Labs
GeekWire
Adaptive Biotechnologies posts $26.3M in Q3 revenue, inks partnership with GlaxoSmithKline
SiliconANGLE
GlaxoSmithKline revolutionizes its R&D pipeline with Docker Enterprise
CNBC Tech
British pharma giant GlaxoSmithKline tells staff to turn off contact-tracing app while at work
Xconomy
GlaxoSmithKline Multiple Myeloma Drug Earns FDA’s First Anti-BCMA Nod
Pulse 2.0
Sanofi And GlaxoSmithKline Sign $2.1 Billion Vaccine Deal With U.S. Government
Pulse 2.0
GlaxoSmithKline (GSK) Buying 10% Of CureVac For £130 Million
MedCity News
FDA panel to review GlaxoSmithKline multiple myeloma drug next month
Xconomy
GlaxoSmithKline Keeps Oncology 2.0 Growth Plans on Track
DealStreetAsia
GSK sells $3.35b stake in Unilever’s India business
Bloomberg Technology
GlaxoSmithKline to Sell $3.3 Billion Unilever India Stake
DealStreetAsia
GlaxoSmithKline said to eye sale of $3.9b stake in India’s HUL
Pulse 2.0
GlaxoSmithKline Invests $250 Million In Vir Biotechnology As Part Of A Strategic Deal
PE HUB
,
Xconomy
COI Pharmaceuticals acquires Calporta by Merck
Xconomy
After Investing, GSK to Buy Out Celiac Drug Developer Sitari Pharma
MedCity News
GlaxoSmithKline steps into the myeloma game at European hematology conference
MedCity News
AI drug development partnership between GlaxoSmithKline, Exscientia yields first drug candidate
Reuters Top News
GlaxoSmithKline to look for early-stage assets: CEO
PE HUB
GSK slides after buying cancer firm Tesaro for hefty $5.1 billion: Reuters
MedCity News
GlaxoSmithKline to buy cancer-focused Tesaro for $5.1 billion
